Skip to content
Cerevention
  • Products
    • MindsEye™ Expandable Port
    • Neurapheresis™ CSF Management System
    • DepiCT™ Neuroimaging Platform
  • Company
    • News
  • Contact
October 4, 2017 | News

In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis

October 4, 2017 – Duke University Medical Center/Minnetronix Neuro Cryptococcal Meningitis is caused by Cryptococcus neoformans and is the most…

Read Article
July 6, 2016 | News

Minnetronix Leverages NIH Funding for Success

The National Institutes of Health (NIH) funds the largest portion of public-sector health research in the U.S., and biomedical research…

Read Article
  • «
  • 1
  • 2
  • 3

Cerevention
1635 Energy Park Drive
St. Paul, MN 55108
P: 651-917-4060
info@cerevention.com

Minnetronix is a trademark of Minnetronix Medical, Inc. MindsEye is a trademark of Minnetronix Neuro, Inc. Cerevention is a trademark of Minnetronix Neuro, Inc.
Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician.

Neurapheresis is a trademark of Minnetronix Neuro, Inc.
Caution: Investigational Device. Limited by Federal (U.S.A.) law to investigational use only.

DepiCT is a trademark of Minnetronix Neuro, Inc.
DepiCT Neuroimaging Platform is currently under development. All subsequent material represents intended use.

LinkedIn Facebook Twitter Twitter
© 2025 Minnetronix Neuro. All rights reserved.